PharmaResearch

PharmaResearch acquires CG USA, a cosmetics manufacturer specializing in OEM and ODM services, to expand REJURAN Cosmetics’ presence in North and South America. The move follows rising demand for REJURAN’s products in the United States. CG USA’s capabilities will support production and distribution for the growing brand.

Jul 2026TNGlobalNews article

REJURAN Cosmetics debuts in U.S. Sephora stores after a Los Angeles pop-up event draws over 5,000 attendees. The brand’s Turnover Ampoule and Dual Effect Ampoule products sell out during the event, signaling high consumer demand. The launch expands the company’s retail presence in North America.

Apr 2026Global Cosmetics NewsNews article

PharmaResearch projects **500 billion won in annual sales** following the development of a **salmon DNA-based skin-regeneration injection**. The company extracts **polynucleotide (PN) and polydeoxyribonucleotide (PDRN)**—key components for tissue regeneration—from **salmon testes and semen**. Founded in 2001 by Chairperson Jeong Sang-su, PharmaResearch expanded rapidly after commercializing these compounds.

Oct 2025ChosunBizNews article

PharmaResearch partners with VIVACY to distribute its **Rejuran** medical device brand across Europe. VIVACY, a France-based global medical aesthetics company, will handle distribution under the new agreement. The partnership expands PharmaResearch’s reach in the European medical aesthetics market.

Aug 2025PA Media Press Release HubNews article